Understanding Non-Radiographic Axial Spondyloarthritis (nr-axSpA): A Guide for Indian Patients

What is Non-Radiographic Axial Spondyloarthritis (nr-axSpA)? Non-radiographic axial spondyloarthritis, often shortened to nr-axSpA, is a chronic inflammatory condition that primarily affects the spine and the pelvis. It is considered an immune-mediated condition, meaning the body's own immune system plays a role in its development. While the exact underlying causes are not fully understood, it is believed to be a part of a spectrum of conditions known as axial spondyloarthritis (axSpA). Nr-axSpA represents one end of this spectrum, characterized by inflammation in the sacroiliac (SI) joints – the joints connecting the base of your spine (sacrum) to your pelvic bones (ilium) – but without significant visible damage on standard X-rays. These SI joints are crucial for supporting your body's weight when standing, providing shock absorption, and maintaining stability. The key difference between nr-axSpA and its counterpart, ankylosing spondylitis (AS), which is sometimes called radiographic axial spondyloarthritis (r-axSpA), lies in the visibility of damage on X-rays. In AS, clear damage to the SI joints is visible on X-rays, whereas in nr-axSpA, such damage is either absent or not clearly discernible on plain radiographs. Causes of Non-Radiographic Axial Spondyloarthritis The precise reasons why some individuals develop axSpA and its subtypes like nr-axSpA are not fully understood. However, several factors are thought to contribute: Genetics: A genetic predisposition plays a significant role. The most commonly implicated gene is HLA-B27. It's important to note that having the HLA-B27 gene does not guarantee that you will develop axSpA, but it increases the risk. Immune System Response: Research suggests that both the innate and adaptive immune systems are involved in the development and progression of axSpA. Innate immunity is the body's general defense against threats like viruses and bacteria. Adaptive immunity is a more targeted response involving specialized antibodies. While overactive adaptive immunity is typical in many autoimmune conditions where the body attacks its own cells, the involvement of innate immunity in axSpA suggests that other immune processes might indirectly cause inflammation. Environmental Factors: Some individuals may develop axSpA following exposure to certain bacterial or viral infections. Physical Trauma or Stress: Physical trauma from injuries, repetitive stress on the body, or poor body mechanics can also be contributing factors for some people. Symptoms of nr-axSpA The symptoms of nr-axSpA often begin before the age of 40 and can vary in intensity. The hallmark symptom is: Inflammatory Lower Back Pain: This pain is typically present for more than three months. It often improves with exercise and worsens with rest. It may also be accompanied by stiffness, especially in the morning. Other potential symptoms include: Pain and stiffness in other parts of the spine and pelvis. Pain in the buttocks, which can sometimes radiate down the leg. Fatigue. Peripheral joint pain or swelling (less common than back pain). Enthesitis: Inflammation where tendons or ligaments attach to bone, often felt in the heels or feet. Eye inflammation (uveitis), causing redness, pain, and blurred vision. In some cases, inflammation can affect other organs like the lungs or heart, though this is less common. Diagnosis of nr-axSpA Diagnosing nr-axSpA can be challenging because the characteristic changes are not visible on standard X-rays. The diagnostic process typically involves: Medical History and Physical Examination: Your doctor will ask about your symptoms, their duration, and any family history of inflammatory arthritis. They will also perform a physical exam to assess your range of motion and check for tenderness. Imaging Tests: While X-rays may not show clear damage, Magnetic Resonance Imaging (MRI) is often used. MRI can detect inflammation in the SI joints and spine that may not be visible on X-rays. Sacroiliitis, which is inflammation of the SI joints, is a key finding. A classification of grade 2 or higher in the SI joints on imaging indicates clear changes. Blood Tests: Blood tests can help identify inflammatory markers, such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), which are elevated during inflammation. Genetic screening for the HLA-B27 gene may also be performed, as its presence can support a diagnosis, although it's not definitive on its own. Treatment for nr-axSpA The goal of treatment for nr-axSpA is to manage pain and stiffness, reduce inflammation, prevent joint damage, and maintain physical function. Treatment plans are often personalized and may include: Medications: Nonsteroidal Anti-inflammatory Drugs (NSAIDs): These are often the first line of treatment for pain and inflammation. Disease-Modifying Antirheumatic Drugs (DMARDs): If NSAIDs are not sufficient, DMARDs may be prescribed. Biologic Agents: These are newer medications that target specific parts of the immune system to reduce inflammation. They are often used for more severe cases. Physical Therapy and Exercise: Regular exercise is crucial for maintaining flexibility, strength, and posture. A physiotherapist can guide you on appropriate exercises. Lifestyle Modifications: Maintaining a healthy weight, quitting smoking, and managing stress can also be beneficial. Prognosis and Progression AxSpA conditions can lead to progressive damage, especially if left untreated. However, the course of the disease varies significantly from person to person. It's important to know that nr-axSpA does not always progress to ankylosing spondylitis (AS). Estimates suggest that only about 5% to 30% of individuals with nr-axSpA will eventually develop significant SI joint involvement visible on X-ray, leading to a diagnosis of AS. Prevention and When to Consult a Doctor While nr-axSpA cannot be entirely prevented due to its complex genetic and immune-related causes, managing risk factors and seeking early diagnosis is key. If you experience persistent lower back

In summary, timely diagnosis, evidence-based treatment, and prevention-focused care improve long-term health outcomes.